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Abstract
Cytoplasmic presence of Hsp60, which is principally a nuclear gene-encoded mitochondrial chaperonin, has frequently been
stated, but its role in intracellular signaling is largely unknown. In this study, we demonstrate that the cytosolic Hsp60
promotes the TNF-a-mediated activation of the IKK/NF-kB survival pathway via direct interaction with IKKa/b in the
cytoplasm. Selective loss or blockade of cytosolic Hsp60 by specific antisense oligonucleotide or neutralizing antibody
diminished the IKK/NF-kB activation and the expression of NF-kB target genes, such as Bfl-1/A1 and MnSOD, which thus
augmented intracellular ROS production and ASK1-dependent cell death, in response to TNF-a. Conversely, the ectopic
expression of cytosol-targeted Hsp60 enhanced IKK/NF-kB activation. Mechanistically, the cytosolic Hsp60 enhanced IKK
activation via upregulating the activation-dependent serine phosphorylation in a chaperone-independent manner.
Furthermore, transgenic mouse study showed that the cytosolic Hsp60 suppressed hepatic cell death induced by
diethylnitrosamine in vivo. The cytosolic Hsp60 is likely to be a regulatory component of IKK complex and it implicates the
first mitochondrial factor that regulates cell survival via NF-kB pathway.
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Introduction
Mammalian cells express a number of survival genes that play
the roles in inhibiting caspase activation, removing harmful
oxygen radicals, defending mitochondrial function, and checking
cell cycle. Among the transcription factors responsible for the
induction of the survival genes, nuclear factor-kB (NF-kB) is a key
element that orchestrates the complex cell survival response [1]. In
particular, the NF-kB-dependent survival genes include anti-
apoptotic genes, such as c-IAPs and c-FLIP, and mitochondrial
safeguard genes, such as manganese-superoxide dismutase
(MnSOD) and Bcl-2 family members [2,3,4]. A central kinase in
NF-kB activation pathway is the inhibitor of kB kinase (IkB kinase
or IKK) that phosphorylates the IkB protein in two amino-
terminal serine residues, leading to its ubiquitinylation and
proteosomal degradation and to the consequent liberation of
NF-kB proteins [5]. The extracellular stimuli to activate NF-kB
pathway converge to IKK [6]. Therefore, numerous efforts have
been made to delineate the regulation of IKK activation. First, the
phosphorylation-dependent regulation of IKK activation has been
characterized [7]. The phosphorylation of two serine residues (Ser
177/Ser181 in human IKKb) in activation T-loop is essential for
activation, while the autophosphorylation of carboxyl-terminal
serine cluster turns off the activation. Many kinases have been
implicated to be involved in the activation phosphorylation: NF-
kB-inducing kinase (NIK) [8,9], mitogen-activated protein kinase/
ERK kinase kinases 1 (MEKK1) [10], MEKK2/3 [11,12],
Hematopoietic progenitor kinase-1 (HPK1) [13], Mixed-lineage
kinase 3 (MLK3) [14], TGF-b activated kinase 1 (TAK1) [15].
However, except TAK1, it is unclear how the upstream kinase
activates the IKK complex. Second, the ubiquitin-dependent
regulation of IKK activation has been studied for many years
[15,16]. Recently, the regulatory subunit IKKc (or NEMO) of
IKK complex has been shown to be ubiquitinated, as well as to
recognize Lys63-linked polyubiquination chain on receptor-
interaction protein 1 (RIP1) [17,18]. Thirdly, the regulation of
IKK activation via the interacting proteins has been characterized.
The best examples are heat shock proteins. For example, Cdc37
and Hsp90 have been reported to act as additional components of
the IKK complex that stabilize the complex [19,20]. Hsp27 has
been shown to interact with IKKb in a TNF-a-dependent manner
[21]. Hsp70 also interacts with IKKc but interferes with the IKK
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tase 2Cb (PP2Cb) and the IKK complex has been demonstrated
[23], and ELKS has also been identified as a new regulatory
subunit of IKK complex that mediates the recruitment of IkBt o
the complex [24]. However, there is no indication of a
mitochondrial protein involved in the IKK/NF-kB activation.
We have recently identified heat shock protein 60 (Hsp60) as an
IKK-interacting protein. Hsp60 is the mitochondrial chaperonin
that promotes the folding of the imported protein to native
conformation. Nonetheless, the existence and function of Hsp60 in
extramitochondrial compartments has frequently been stated [25].
For example, Hsp60 can be a ligand for cell-surface receptors like
toll-like receptor [26]. Intracellularly, Hsp60 has been shown to
interact with pro-caspase-3 or Bax [27,28,29]. However, the
function of Hsp60 related to cell survival signaling has not been
reported. In this study, Hsp60 was found to mediate the NF-kB-
dependent survival signaling in the cells. Specifically, Hsp60
directly interacted with IKKa/b in cytoplasm and then promoted
the phosphorylation-dependent activation of the kinase in response
to TNF-a. Such signaling function of Hsp60 was independent of
its chaperone activity, which sets Hsp60 apart from other heat
shock proteins that function via stabilizing or destabilizing
signaling complex [30]. We also showed in vivo evidence that
cytosolic expression of Hsp60 protects hepatic cells against
chemical-induced damages via enhancing IKK activation. Thus,
this finding represents the novel pro-survival function of cytosolic
Hsp60 and shed a light on understanding the function of Hsp60 in
extra-mitochondrial compartments [25].
Results
Hsp60 interacts with IKK complex in cytoplasm
To identify an additional component, we examined the
molecular composition of the latent IKK complex using a
proteomic technique combining immuno-affinity purification and
mass spectrometry. Briefly, the IKK complex was precipitated
from the lysates of unstimulated HeLa S3 cells using anti-IKKa
antibody beads, and the co-precipitated proteins were sequenced
by liquid chromatography-tandem mass spectrometry. The
identification of the IKK subunits and Hsp90 indicated that the
immunopurification of IKK complex fairly worked (Fig. 1A). As a
consequence, this proteomic study identified a heat shock protein,
Hsp60, in the precipitates (Fig. 1A and 1B). The presence of the
IKK subunits and Hsp60 in the precipitates was confirmed by
immunoblotting (Fig. 1C). Then, we decided to investigate the
biological meaning of the IKK-Hsp60 interaction.
The first step was to verify the endogenous interaction of Hsp60
and IKKs by co-immunoprecipitation experiments. When the
heterogeneous IKK complexes were precipitated with antibodies
against IKKa, IKKb, and IKKc, each of the IKK subunit-specific
antibodies similarly precipitated Hsp60 (Fig. 1D). In addition,
Hsp90 was also co-precipitated with IKK complex [20,21]. This
interaction was found to be unaffected by TNF-a treatment
(Fig. 1E), indicating that Hsp60 is a component protein of
heterogeneous IKK complexes. A reverse immunoprecipitation
was then carried out with the cytosolic fraction to exclude the
mitochondrial contamination. The anti-Hsp60 antibodies co-
precipitated IKKc with Hsp60, whereas control goat IgG did
not (Fig. 1F), confirming that cytosolic interaction of Hsp60 and
IKK. In order to visualize the virtual interaction of Hsp60 with
IKKs in cytoplasm, the immunogold staining combined with the
electron microscopy (EM) was performed. The immune complexes
of Hsp60 and IKK with their specific antibodies were detected
differently using secondary antibodies labeled with 20 nm- and
40 nm-diameter gold particles, respectively. As a result, the
Hsp60-labeling gold particles were distributed throughout the
cellular structures: not only in the matrix and intermembrane
space of mitochondria, but also in the cytoplasm and plasma
membrane (Fig. 2B). In contrast, the IKKa- and IKKb-labeling
gold particles were mainly detected in the cytoplasm (Fig. 2C and
2D), while the IKKa was also detected in the nucleus, which is
consistent with the previous reports [31,32]. Although the IKK
core subunits have been shown to be found in the mitochondrial
fraction [33], our data showed that the IKK-labeling gold particles
were often seen in the vesicular structures rather than the
mitochondria (Fig. 2C and 2D). This discrepancy might be due
to the previous study done with subcellular fractionation. When
the Hsp60 and IKKs were co-stained, the direct binding of 20 nm
and 40 nm gold particles was clearly detected in the cytoplasm
(Fig. 2E and 2F). It should be noted that not all of the IKKa and
IKKb were associated with Hsp60. These results collectively
indicate that the Hsp60 directly interacts with IKK complex in the
cytosol.
Hsp60 directly interact with IKKa/b, not IKKc
Next, we analyzed the molecular interaction of Hsp60 and
IKKs. To do this, a cytosol-targeted version of Hsp60 (Hsp60c),
wherein the mitochondrial targeting signal sequence is deleted,
was constructed. When Hsp60c was co-expressed with each of the
IKK core subunits, Hsp60c interacted with IKKa and, albeit to a
lesser extent, with IKKb, but not with IKKc (Fig. 3A). Then, an in
vitro binding experiment using the recombinant proteins of
glutathione-S-transferase (GST)-fused Hsp60 and (His)6-tagged
IKK core subunits was assessed by a GST pull-down assay. The
result, again, indicates that Hsp60 binds directly to IKKa and
IKKb, but not to IKKc (Fig. 3B).
The molecular interaction of Hsp60 with IKK was further
characterized by domain mapping experiments. Because the C-
terminal deletion hampered the ectopic expression, a series of N-
terminal deletion mutants of Hsp60c was tested for IKK binding
via co-expression with Flag-tagged IKKa in HEK293 cells
(Fig. 3C). The results showed that the N-terminal part (,160
amino acids from N-terminus) of Hsp60 protein was shown to be
dispensable for the interaction (Fig. 3D). The same result was
obtained when endogenous IKK complex was immunoprecipitat-
ed from HeLa cells transfected with the Hsp60c constructs
(Fig. 3E). The results fairly indicate that the core binding domain is
located in the middle of Hsp60 protein.
Hsp60 is involved in the IKK/NF-kB activation
Next, the biological effect of cytosolic Hsp60-IKK interaction
was investigated in TNF-a-mediated NF-kBp a t h w a y .T o
achieve the goal, the essential step is to manipulate the level of
cytosolic Hsp60 without affecting the mitochondrial one because
Hsp60 deficiency is known to cause a mitochondrial functional
defect [34,35,36]. Interestingly, a number of studies has
previously reported that an antisense oligodeoxynucleotide (AS-
ODN) complementary to a sequence surrounding the start codon
of the human Hsp60 open reading frame actually reduces the
cytosolic Hsp60 level [27,37,38]. We, therefore, decided to test
this AS-ODN (designated as AS-1) for a selective knockdown
effect. In order to exclude the possibility of non-specific action of
a particular ODN sequence, we chose a second AS-ODN (AS-2)
that is complementary to the region (+95,+110 from start
codon) near the 59 end, but after mitochondrial targeting signal
sequence (MTS), of Hsp60 open reading frame (Fig. S1A). The
sense ODN (S-ODN) complementary to AS-1 was used as a
control ODN. Since the antisense ODN is a moderate
Hsp60 for IKK Regulation
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level (Fig. S1B). However, the transfection of AS-ODNs indeed
selectively reduced cytosolic Hsp60 levels compared to the mock
or control S-ODN without affecting the mitochondrial level
(Fig. 4A). To understand this phenomenon, we hypothesized that
the half-life of Hsp60 protein in two compartments may differ.
To prove it, the half-life of cytosol-targeted Hsp60 (Hsp60c) was
assessed after inhibition of protein synthesis. Surprisingly, the
level of cytosolic Hsp60 protein was rapidly reduced (calculated
tK=3.2 min), while total level of endogenous Hsp60 and IKKa
proteins was unchanged (Fig. 4B). Moreover, this reduction was
completely blocked by the treatment of a proteasome inhibitor
MG132 (Fig. 4C). It is noted that the MG132 treatment also
resulted in the remarkable increase of the basal level of the
Hsp60c protein. Thus, this result, at least in part, explains why
the level of cytosolic Hsp60 was more sensitive to AS-ODN
treatment, and it additionally suggests that the level of cytosolic
Hsp60 might be controlled by proteasome.
The TNF-a-induced IKK/NF-kB activation was then exam-
ined in the AS-ODN-transfected cells. An in vitro kinase assay
showed that the transfection of AS-ODNs appreciably reduced the
IKK activation in response to TNF-a by 60% compared to that of
the mock or S-ODN (Fig. 4D). However, the AS-ODNs had no
effect on the MAP kinase activation in response to TNF-a (Fig. 4D
and Fig. S1C), revealing the specific effect of the Hsp60 AS-ODNs
on IKK activation. Furthermore, the AS-ODNs almost completely
abolished the NF-kB transcriptional activation in response to
TNF-a, whereas S-ODN did not, compared to mock-treated cells
(Fig. 4E). Owing to its knockdown efficacy, AS-1 is more potent
that AS-2. However, the transfection of ODNs itself did not induce
basal NF-kB activation, indicating no off-target effect of ODNs. In
addition, the reductive effect of AS-ODNs on NF-kB transcrip-
tional activity was also evident in 293T and A549 cells (Fig. S1D).
An additional control experiment showed that the AS-ODNs had
no affect other transcription factor activation, such as AP-1, NF-
AT, and CRE (Fig. S1E).
Figure 1. Identification of Hsp60 in IKK complex. A. A silver-stained polyacrylamide gel resolving the affinity-purified IKK complex. B. MS/MS
spectra of [M+2H]
2+ ions of the peptides derived from the protein band corresponding to Hsp60. C. Immunoblot (IB) analyses of IKK subunits and
Hsp60 in the affinity-purified complex. D. Interaction of Hsp60 with IKK complex. IKK complex was immunoprecipitated (IP) from HeLa cell lysates
(500 mg total proteins for each) with IKKa, IKKb, and IKKc-specific antibodies. The IKKa/b/c subunits, Hsp60, and Hsp90 were immunoblotted. WCL,
whole cell lysate. E. TNF-a-independent interaction of Hsp60 and IKK complex. F. Co-immunoprecipitation of Hsp60 and IKK complex in cytosolic
fraction. Upper panel, post-nuclear supernatant (PNS), cytosol (Cyto), and mitochondria (Mito) fractions from HeLa cells were immunoblotted. COX4
and tubulin were used as mitochondrial and cytosolic markers, respectively. Lower panel, Hsp60 was immunoprecipitated from the cytosolic fraction
using either control goat IgG or anti-Hsp60 antibodies (K-19 and N-20). Representative blots are shown (n=3).
doi:10.1371/journal.pone.0009422.g001
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using a specific antibody (Hsp60N), which has been used for
immunoprecipitation and immunostaing of Hsp60 (see Fig. 1).
The antibody transduction was achieved by a peptide-mediated
protein delivery system [39]. The control goat IgG and Hsp60N
antibody were found to be successfully delivered to cytoplasm, as
being not merged with Mitotracker (Fig. 5A), and Hsp60N, but
not control IgG, bound to Hsp60 (Fig. 5B). This result indicates
that the delivered antibody can act as a function blocker. Then,
IKK/NF-kB activation was examined in antibody-transduced
cells. The Hsp60N antibody evidently reduced the IKK activation
in response to TNF-a by 50% of the level obtained with the
control IgG (Fig. 5C). In contrast, TNF-a-induced JNK activation
was not affected, which again proves that the role of Hsp60 is
specific to the IKK activation. Consistently, the Hsp60N antibody
significantly reduced the transcriptional activity of NF-kB
(Fig. 5D). The data collectively conclude that cytosolic Hsp60
promotes the TNF-a-induced IKK/NF-kB signaling.
Ectopic expression of cytosol-targeted Hsp60 sufficiently
promotes IKK/NF-kB activation
Conversely, the role of cytosolic Hsp60 in IKK/NF-kB pathway
was addressed by over-expression of cytosol-targeted Hsp60c. The
ectopically-expressed Hsp60c was found to associate with the IKK
complex (Fig. 6A) and markedly enhanced the IKK and NF-kB
activation in response to TNF-a (Fig. 6B and 6C). It should be
noted that the ectopic expression of Hsp60c marginally induced
the basal IKK and NF-kB activation. The effect of Hsp60c
expression in NF-kB activation was completely abolished in
IKKb-deficient cells (Fig. 6D), indicating that the regulatory
activity of cytosolic Hsp60 is IKK-dependent. In addition, the
ectopic expression of Hsp60c did not enhance either JNK
activation or the activation of other transcription factors such as
AP-1, CRE, and NF-AT (Fig. S2). This result indicates that
increasing the cytosolic Hsp60 level augments TNF-a-induced
IKK/NF-kB activation.
Hsp60 regulates IKK phosphorylation at the activation T-
loop
To understand the mechanism underlying the regulatory action
of Hsp60 in IKK/NF-kB activation, several experimental
approaches were attempted. To determine whether the chaperone
activity of Hsp60 is required, the two amino acid residues that are
known to be critical for the chaperone activity of Hsp60 were
considered. One is a lysine residue (K28), which is involved in the
oligomerization of Hsp60 protein [40,41]. The other is an
aspartate residue (D423), which is an active site residue for
ATPase activity [42,43]. Thus, the Hsp60c mutants, wherein K28
and D423 are substituted with glutamate and alanine respectively,
were constructed. The co-transfection experiment showed that
both mutants interacted with IKKa and IKKb as well as or
perhaps even better than the wild type (Fig. 7A). The IKK
activation in response to TNF-a in the Hsp60 mutant-expressing
cells was similar to that in the wild type (Fig. 7B), indicating that
such loss-of-function mutations did not affect the IKK-enhancing
activity. Furthermore, TNF-a-induced NF-kB transcription was
even enhanced in the Hsp60 mutant-expressing cells at approx-
imately 4–6 times higher than that in the vector control (Fig. 7C).
The enhancing effect of the mutants was clearly IKKb-dependent,
as tested again in IKKb-deficient 3T3 cells. Thus, this experiment
Figure 2. Visualization of Hsp60 and IKK interaction at a single-cell level. HeLa cells were immunoreacted with no primary (A), anti-Hsp60
(B), anti-IKKa (C), anti-IKKb (D), anti-Hsp60/IKKa (E), and anti-Hsp60/IKKb (F) antibodies, and then labeled with the corresponding secondary
antibodies conjugated with 20 nm or 40 nm gold particles, as described in Experimental Procedure. The labeling was assessed by immuno-gold
electron microscopy. Nuclei (Nu) and mitochondria (M) are indicated. Arrows indicate direct adherence of Hsp60- and IKK-labeled gold particles. No
immunoreactive signal was seen in the sample without primary antibodies (A). The experiments were repeated twice with the same results, and
representative results are shown.
doi:10.1371/journal.pone.0009422.g002
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cytosolic Hsp60 functions independently of chaperone activity in
IKK/NF-kB activation.
One of the IKK-interacting protein, ELKS, has been shown to
mediate the IkB recruitment to IKK complex [24]. To test this
mode of action, the recombinant Hsp60 protein was directly
added into the IKK kinase reaction, where the activated IKK
complex is incubated with full-length human IkB as a substrate.
The in vitro kinase activity of the activated IKK toward IkB was
not affected by the presence of Hsp60 protein (Fig. 7D), indicating
that Hsp60 is not involved in the interaction of IKK and its
substrate IkB.
Lastly, a direct involvement of cytosolic Hsp60 in IKK
activation was addressed by examining the activation-dependent
serine phosphorylation in the T-loop of IKKa/b. The AS-ODN
transfection markedly abolished the TNF-a-induced phosphory-
lation of IKK at Ser178/181, indicating that the phosphorylation-
dependent IKK activation was impaired (Fig. 7E). Conversely, the
ectopic expression of Hsp60c resulted in an increase of IKK
phosphorylation (Fig. 7F). Overall, the data indicate that the
cytosolic Hsp60 is involved in the phosphorylation-dependent
IKK activation, rather than the chaperone-dependent stabilization
of IKK complex.
Cytosolic Hsp60 affects the NF-kB target gene expression
and cell survival
To determine the significance of cytosolic Hsp60-mediated
regulation of the IKK/NF-kB pathway, we examined the
expression of NF-kB target genes in ODN-transfected cells. When
the expression of anti-apoptotic genes was screened by a RNase
protection assay [44], the expression of TRAF1, c-IAP1, and c-
IAP2 were not affected by AS-ODN transfection (Fig. 8A). This
was unexpected but led us to postulate a possibility that some select
target genes related to mitochondrial protection can be affected.
To test this, we looked at the induction of several target genes,
including antioxidant proteins (ferritin heavy chain and MnSOD)
and Bcl-2 members (Bcl-2, Bcl-XL, Bfl-1/A1). Interestingly, the
AS-ODN significantly diminished the induction of only MnSOD
and Bfl-1/A1 expression in response to TNF-a (Fig. 8B). The
Hsp60N antibody also significantly reduced the induction of these
genes (Fig. 8C). It was again confirmed that the induction of the c-
IAP2 expression was not affected in either case. Thus, the results
Figure 3. Hsp60 directly interacts with IKK complex. A. Direct binding of Hsp60 and IKK subunits. The 293T cells were co-transfected with
Hsp60c (HA tag) and each of IKK subunit proteins (Flag tag) for 24 hrs. B. In vitro association of Hsp60 with IKKa and IKKb. GST-fused Hsp60 proteins
bound to the glutathione Sepharose beads was incubated with the lysates of Sf9 insect cells expressing His6-tagged IKK proteins. Hsp60 and IKKs
were detected by immunoblotting for GST and HA tags, respectively. C. Schematic diagram showing deletion mutants of Hsp60. The putative
phosphorylation sites of kinases, including PKA/PKG (1) and PKC (2), are indicated. D and E. Interaction of Hsp60 wild-type (WT) and deletion mutants
with ectopically-expressed IKKa in 293T cells (D) or to endogenous IKK complex in HeLa cells (E). The control vector (C) is indicated. Representative
blots and images are shown (n=3). n.s., nonspecific.
doi:10.1371/journal.pone.0009422.g003
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Hsp60 influences the expression of select NF-kB target genes.
We next wondered whether such regulation of select target
genes has an impact on cell survival. Since there is a possibility that
MnSOD and Bfl-1/A1 function to suppress the mitochondrial-
derived reactive oxygen species (ROS) [2,45], the level of cellular
ROS was examined in ODN-transfected cells using an oxidation-
sensitive fluorescence dye, CM-H2DCFDA. The AS-ODN
transfection induced a marked increase of cellular ROS in
response to TNF-a treatment in a time-dependent manner,
compared to mock or S-ODN transfection (Fig. 8D). Since the
enhanced ROS level is linked to cell death via the sustained JNK
activation [46], the sustained activation of stress-activated protein
kinases, JNK and p38 MAPK, was examined. Unexpectedly, the
activation of both JNK and p38 MAPK were found to be clearly
sustained in AS-ODN-transfected cells (Fig. 8E). The ASK-1
MAP3K is known to be responsible for the sustained activation of
JNK and p38 in the ROS-mediated cell death [47]. Indeed, the
ASK-1 activation was significantly induced in AS-ODN-transfect-
ed cells (Fig. 8F). As a consequence of this signaling pathway
including ASK-1 activation, the AS-ODN resulted in a marked
induction of TNF-a-induced cell death in HeLa cells, whereas the
mock or S-ODN did not at all (Fig. 8G). Likewise, the AS-ODN
enhanced TNF-a-induced cell death in colon carcinoma cell lines,
which showed significant level of cytosolic Hsp60 (Fig. 8H). It
should be noted that the AS-ODN transfection by itself resulted in
the basal activation of ROS, ASK1, and cell death. Along with the
evidence that the Hsp60c overexpression induced the basal IKK/
Figure 4. Loss of cytosolic Hsp60 diminishes IKK/NF-kB activation in response to TNF-a.A . Ablation of cytosolic Hsp60 by antisense
ODNs. The cytosolic and mitochondrial fractions prepared from mock or ODN-transfected HeLa cells were immunoblotted. S, sense ODN; AS-1 and
AS-2, antisense ODNs. The mitochondrial fraction was loaded at a volume of one-fifth of the corresponding cytosolic fraction. In particular, Prx III,
which is an antioxidant enzyme present in the mitochondrial matrix, was used as mitochondrial markers to watch the nonspecific mitochondrial
rupture. B. Half-life of ectopically-expressed Hsp60c protein (HA tag) after inhibition of protein synthesis with cycloheximide. The intensity of HA
band was measured and normalized by the amount of IKKa band. Data in the graph are means 6 S.D. of two independent experiments and fitted in
SigmaPlot 8.0 software. C. Proteasome-dependent turnover of cytosolic Hsp60c protein. HeLa cells were pretreated with or without MG132 (5 mM)
30 min before cycloheximide treatment. D. TNF-a-induced IKK and JNK1 activation in mock or ODN-transfected cells. The in vitro kinase activity (KA)
was averaged with the values from two independent experiments, and it is represented as a fold increase of the activity versus the unstimulated and
mock-transfected cells (lane 1). E. NF-kB transcriptional activation in mock or ODN-transfected cells. The increasing concentration of AS-ODN (100 nM
or 200 nM) was tested. The relative luciferase activity was normalized to the b-galactosidase activity and data are means 6 S.D. of four independent
experiments (*P,0.0001, **P,0.001 versus stimulated S-ODN-transfected cells).
doi:10.1371/journal.pone.0009422.g004
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cell survival in resting cancer cells. Collectively, our results suggest
that the selective regulation of MnSOD and Bfl-1/A1 expression
by cytosolic Hsp60 sufficiently influences cell survival via
suppressing mitochondrial ROS burst.
Cytosolic Hsp60 protects host cells against stressed
conditions
Next, the pro-survival activity of cytosolic Hsp60 was
investigated in vivo. To do this, transgenic mice expressing
Hsp60c were generated (Fig. 9A and 9B). The Hsp60c protein
was successfully expressed in various tissues, including liver,
spleen, and lung (Fig. 9C). The IKK activation was markedly
enhanced in the Hsp60c-expressing transgenic mice compared to
the control B6 mice when TNF-a was intravenously injected
(Fig. 9D). The result indicates that the cytosolic Hsp60 enhanced
the TNF-a-induced IKK activation in vivo.W et h e ns o u g h ta n
animal model wherein the IKK/NF-kB-dependent cell survival
is involved: the diethylnitrosamine (DEN)-induced hepatocyte
death [48]. The apoptotic cell death of hepatocytes was indeed
increased after DEN injection in four-week-old male mice (Fig.
S3). Therefore, the DEN-induced hepatic cell death was
examined in Hsp60c-expressing transgenic mice that had been
primed with or without TNF-a. TUNEL staining of the liver
tissue sections showed that the hepatic cell death was significantly
reduced in Hsp60c-expressing transgenic mice compared to
control mice (Fig. 9E and 9F). The data indicate that the cytosolic
Hsp60 prevents the stress-induced cell death in vivo by promoting
IKK/NF-kB activation.
Discussion
The present study demonstrates that the cytosolic Hsp60
interacts with the IKK complex and enhances its activation. This
signaling action of cytosolic Hsp60 affects the induction of the two
NF-kB target genes, Bfl-1/A-1 and MnSOD, and thus cell
survival. Since Bfl-1/A-1 functions as a tBid and Bak antagonist
[2,4] and MnSOD eliminates the superoxide anion inside
mitochondria [49], these two genes are ultimately critical for
controlling mitochondrial-derived ROS. Indeed, ablation of
cytosolic Hsp60 results in the increase of cellular ROS, which in
turn triggers the sustained activation of JNK/p38 via ASK-1 and
finally induces the cell death, in response to TNF-a. Given that the
mitochondrial ROS are causally linked to various human diseases
such as cancer, vascular damage, and a variety of degenerative
diseases via the accumulation of cellular damage, this new pro-
survival circuitry mediated by cytosolic Hsp60 may be of
particular important progression of these diseases.
The transcriptional regulation of select NF-kB target genes by
cytosolic Hsp60 is attractive issue but unsolved in the present study.
The RNase protection assay and the microarray experiment
(,24,000 RefSeq-based probe sequences per array, Illumina
expression chip) were failed to demonstrate the broad effect of the
cytosolic Hsp60 on expression profile of NF-kB target genes.
Instead, the quantitative real-time PCR demonstrated the expres-
Figure 5. Hsp60-specific antibody blocks IKK/NF-kB activation. A. Transduction of Hsp60-neutralizing antibody (Hsp60N) into the cytoplasm
of HeLa cells. Mitotracker Red (Molecular Probes, USA) and DAPI indicate mitochondria and nuclei, respectively. B. The transduced Hsp60N antibody
bound to endogenous Hsp60. After antibody transfection, the HeLa cell lysates were subjected to precipitation using Protein-A Sepharose beads. The
precipitated proteins were immunoblotted for Hsp60. C. IKK and JNK1 activation in response to TNF-a in control IgG or Hsp60N antibody-transfected
HeLa cells. The in vitro kinase activity (KA) was averaged with the values from two independent experiments, and it is represented as a fold increase of
the activity versus the unstimulated and control IgG-transfected cells (lane 1). D. TNF-a-induced NF-kB transcriptional activation in antibody-
transfected cells (*P,0.01 versus stimulated IgG-transfected cells).
doi:10.1371/journal.pone.0009422.g005
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both of which are known to be related to the mitochondrial
function. Although this odd phenomena were hardly investigated in
the study, some experimental data can provide a clue. 1) Hsp60 was
shown to bind preferentially to IKKa rather than to IKKb in the in
vitro protein binding assay. 2) Direct interaction of Hsp60 and
IKKa, but not IKKb, in the nucleus was often observed in the
immunogold staining. IKKa is known to regulate NF-kB
transcriptional activity in the nucleus [31,32] rather than IkB
phosphorylation [50]. Supposedly, when the Hsp60-IKKa complex
translocate to nucleus, the Hsp60 may directly guide IKKa to the
promoter of particular gene set (e.g, MnSOD and Bfl-1/A1). This is
similar to the way exemplified in the regulation of select p53 target
genes by human cellular apoptosis susceptibility (hCAS) protein
[51]. Otherwise, it may be possible that the Hsp60 modulates the
ability of IKKa or presumably IKKb as well, to phosphorylate the
other substrates such as RelA, SMRT, and histone H3 [52], which
thus indirectly affects the NF-kB transcription. For eample, the
IKKa-mediated phosphorylation of SMRT corepressor allows the
recruitment of NF-kB to promotors [53], and IKKa-mediated
phosphorylation of histone H3 affects the chromatin structure
[31,32]. However, our inciting speculation needs an investigation.
On the other hand, the functional significance of Hsp60-IKKa
interaction was also investigated in non-canonical NF-kB
signaling, RANK-induced osteoclastogenesis [54]. IKKa-mediat-
ed NF-kB pathway is essential for RANK-induced osteoclastogen-
esis [55,56]. As shown in Fig. S5, the reduction of cytosolic Hsp60
expression using antisense ODN (AS-1) clearly suppressed the
RANK-induced osteoclast formation from the bone marrow-
derived macrophage/monocytic (BMM) cells, as quantified by
TRAP assay. Since TNF-a-induced osteoclast formation [57] was
also markedly suppressed, this result indicates that cytosolic Hsp60
can function in the NF-kB activation pathway via interacting with
non-canonical as well as canonical IKK complex.
Since Hsp60 is exclusively targeted to mitochondria after
translation, the cytosolic Hsp60 is presumed to be of mitochon-
drial origin. In fact, the mitochondrial release of Hsp60 in
staurosporine-treated Jurkat T cells has been shown [29]. We also
observed the same result in staurosporine-treated HeLa cells (Fig.
S4). Since the Hsp60 protein was detected in the mitochondrial
intermembrane space in immunogold EM data, we believe that
this pool of Hsp60 protein can be released. This is similar to the
case of pro-apoptotic mitochondrial factors. For example, AIF is a
mitochondrial inner membrane protein (62-kDa in mature form)
and is released after proteolytic shedding to a 57-kDa form upon
proapoptotic stimuli [58,59]. HtrA2/Omi (51-kDa serine protease)
is released from the mitochondrial intermembrane space [60,61].
In addition, the fact that the antisense-ODN (AS-1) used in the
Figure 6. Cytosol-targeted expression of Hsp60 promotes TNF-a-induced IKK/NF-kB activation. Cells were transfected with either control
(CGN) or Hsp60c-encoding plasmid (HA tag) for 24 hrs and then treated with TNF-a. A. Incorporation of ectopically-expressed Hsp60c (HA tag) in IKK
complex. B. TNF-a-induced IKK activation in HeLa cells. C TNF-a-induced NF-kB activation in HeLa cells (n=4, *P,0.0001 versus unstimulated
counterpart). D. TNF-a-induced NF-kB activation in the transfected IKKb
2/2 3T3 cells (n=4,*P,0.001 versus stimulated CGN-transfected cells, N.D.
not detected).
doi:10.1371/journal.pone.0009422.g006
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but reduces the level of cytosolic Hsp60 is also supportive.
Hsp60 once located in the cytosol exhibited the faster turnover
compared to the mitochondrial one. Its rapid turnover is
controlled in a proteasome-dependent manner, but it is unlikely
due to the structural instability because the cHsp60 protein lacking
MTS sequence was successfully expressed and purified in soluble
form. Nonetheless, since we cannot exclude the possibility of
natural mitochondrial targeting error, the investigation on how
mitochondrial Hsp60 is released and whether the turnover of
cytosolic Hsp60 depends on ubiquitination is on-going.
Cytosolic Hsps such as Hsp70 and Hsp90 are known to broadly
participate in cell signaling [30]. As a chaperone protein, they
stabilize or destabilize the large signaling protein complexes. Since
the interaction of Hsp60 and IKKcomplex wasunaffectedby TNF-
a stimulation, the mode of Hsp60 action was initially thought to be
the same. However, our results shown suggest a unique feature of
the signaling function of cytosolic Hsp60. Briefly, the polymeriza-
tion-defective orATPase-inactivemutantofHsp60enhancedIKK/
NF-kB activation much more effectively than the wild-type Hsp60
did (see Fig. 8). This suggests that Hsp60 likely functions as a non-
chaperonic monomer rather than a chaperone polymer in
augmenting NF-kB activation. Some experimental evidences also
favorably support the possibility of non-chaperonic function of
cytosolic Hsp60: 1) the introduction of the Hsp60N neutralizing
antibody did not affect the amount of IKK core subunits in the
lysate and immunoprecipitate, and 2) the AS-ODN did not affect
the amount of IKK core subunits in the high-molecular-weight
fractions (.600 kDa) from gel filtration chromatography (data not
shown). These results indicate that the cytosolic Hsp60 is not
involved in the stability of the IKK complex. Rather, our study
clearly demonstrates that cytosolic Hsp60 is involved in the
regulation of IKK phosphorylation in the activation T-loop.
Therefore, the cytosolic Hsp60 may act on either enhancing the
interaction of the IKK complex with an upstream kinase or the
oligomerization-dependent auto-phosphorylation [52]. In any case,
it can be a novel mechanism of the IKK activation in collaboration
with the ubiquitin-dependent mechanism.
In summary, cytosolic presence of Hsp60 is frequently detected
and play signaling roles in the cell types, e.g. cardiac myocytes and
hepatocytes [37,62,63]. And also there are attempts to approach
anti-cancer therapy through understanding the presence and
Figure 7. Cytosolic Hsp60 regulates IKK phosphorylation independently of chaperone activity. A. Association of Hsp60c wild-type (WT)
and mutants with IKKa and IKKb. The indicated proteins were co-expressed in 293T cells as shown in Fig. 3A. B and C. IKK (B) and NF-kB
transcriptional activation (C) in cells expressing Hsp60c wild-type and chaperone-inactive mutants. The kinase and reporter activities were analyzed
as described in Fig. 4 (for reporter assay, n=6, *P,0.0001 versus unstimulated counterpart). D. In vitro kinase activity of IKK in the presence of
recombinant Hsp60 protein. The IKK complex was immunoprecipitated from HeLa cell lysates and incubated with or without the indicated GST
proteins (20 mg each) in the kinase reaction buffer for 10 min before the kinase reaction. E. Serine phosphorylation of IKKa/b in HeLa cells transfected
with AS-1 ODN. Data in the graph are means 6 S.D. (n=3,*P,0.02, *P,0.001). F. Serine phosphorylation of IKKa/b in Hsp60c-expression HeLa cells. A
representative blot is shown (n=3).
doi:10.1371/journal.pone.0009422.g007
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ments [25]. Our study demonstrates for the first time that, by
directly interacting and regulating IKK activation, the cytosolic
Hsp60 serves as survival guidance controlling mitochondrial-
derived ROS through NF-kB target gene expression. Therefore,
either antagonizing the interaction of Hsp60 with IKK or
reducing the level of the cytosolic Hsp60 could be an additional
therapeutic tool in anti-inflammatory strategy.
Materials and Methods
Reagents
Antibodies to IKKa (B-8), IKKc (FL-419), Hsp90 (H-114),
Hsp60 (K-19 and N-20), IkBa (C-21), JNK1 (C-17), ASK-1 (H-
300 and F-9), glutathione S-transferase (B14), and goat IgG were
purchased from Santa Cruz Biotechnology (Santa Crus, US); Anti-
Flag antibody (M2) was purchased from Sigma; Anti-hexahistidine
Figure 8. Loss of cytosolic Hsp60 induces cell death in response to TNF-a by inducing ROS and ASK-1 activation. A. RNase protection
assay for induction of anti-apoptotic genes in ODN-transfected cells. The autoradiogram shown is a representative of three independent experiments. B
andC.QPCRforinductionofendogenous NF-kBtargetgenesinODN-transfectedcells(B)andantibody-transfectedcells(C)(n=3,*P,0.01, **P,0.001).
D. TNF-a-mediated production of cellular ROS in ODN-transfected cells. The representative images are shown. Data are means 6 S.D. of fold increase
versus untreated mock cells of the relative DCF fluorescence (n=4,*P,0.05, **P,0.001). E. JNK and p38 MAPK activation in ODN-transfected cells.
Representative blots are shown. Data in the graphs are means 6 S.D. of the intensities of phospho-JNK (p46) or phospho-p38 bands that had been
normalized by the corresponding non-phospho-bands (n=3,*P,0.05, **P,0.001). F. ASK-1 activation in ODN-transfected cells. The kinase activity (KA)
was averaged with the values from two independent experiments, and presented as a fold increase of the activity versus the unstimulated and mock-
transfected cells (lane 1). G. TNF-a-induced cell death in mock or ODN-transfected HeLa. Data are means 6 S.D. (n=3,*P,0.01). H. TNF-a-induced cell
death of colon carcinoma cells transfected with ODNs. The level of Hsp60 in subcellular fractions is shown (Upper). Data in the graph are means 6 S.D.
(n=3,*P,0.05, **P,0.01). Cell death was analyzed by FACS after staining with annexin V-fluorescein isothiocynate and propidium iodide.
doi:10.1371/journal.pone.0009422.g008
Figure 9. Cytosolic Hsp60 protects hepatic cells in vivo from stress-induced apoptosis via IKK activation. A. Schematic representation of
transgenic vector containing HA-tagged human Hsp60c. B. Identification of two transgenic mouse lines (T4 and T11). Genomic PCR was performed
using two different sets of PCR primers, both of which were specific to Hsp60 transgene. The transgenic vector (V) and C57BL/6j (B6) mouse genomic
DNA were used as positive and negative control, respectively. C. Expression of Hsp60c protein in various tissues of transgenic mice. The tissue
homogenates were immunoblotted using anti-HA antibody. D. IKK activation in the liver of control B6 mice or HA-Hsp60c-expressing transgenic mice
(T4 and T11) intravenously injected with TNF-a. E and F. DEN-induced cell death in the liver of control and transgenic mice primed with or without
TNF-a, as measured by TUNEL assay. The representative images (E) are shown. The quantified data in the graph (F) are means 6 S.E.M. of the number
of TUNEL-positive cells per unit area (n=3,*P,0.01 versus paired stimulated one).
doi:10.1371/journal.pone.0009422.g009
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IKK, IKKa, and IKKb were from Cell Signaling Technology;
Normal mouse and rabbit IgG were from Amersharm Bioscience;
Anti-cytochrome c antibody were from BD Pharmingen; Anti-
bodies to Peroxiredoxin III (Prx III), MnSOD (2AI), Hemagglu-
tinin epitope (HA), and GAPDH were provided by AbFrontier
(Seoul, Korea); Recombinant human TNF-a was purchased from
Invitrogen (Grand Island, USA). The phosphorothioate oligodeox-
ynucleotides (ODNs), including the antisense and sense sequences,
were synthesized by Hokkaido System Sciences Co. (Hokkaido,
Japan). The full-length human IkB protein was a kind gift of W.
Jeong (Ewha Womans University, Korea) [64].
Plasmids
The full-length cDNA of human Hsp60 was obtained from the
National Genome Information Center (Daejon, Korea). A
truncated form of Hsp60, designated as Hsp60c, which lacks a
mitochondrial targeting sequence (MTS; amino acids 1–26 based
on human sequence), was amplified by PCR and subcloned into
the pCGN-HA (a kind gift of Dr. W. Herr, Cold Spring Harbor
Laboratory) and pGEX-4T1 (Amersham) vectors, by which the
HA-tagged and GST-fused Hsp60c expression plasmids, respec-
tively, were constructed.
CRE-, NF-AT-, and AP1-dependent (pAP17x-Luc) firefly
luciferase reporters were obtained from Stratagene. Luciferase
reporter plasmids harboring the IFNb-derived NF-kB enhancer
sequences [65] was a kind gift of S. Y. Lee (Ewha Womans
University, Korea). Human IKK a, b, and c cDNAs [66,67] were
subcloned into the pCMV2-FLAG or baculovirus expression
vector pFastBac-HTa (Invitrogen). The pFastBac contructs,
encoding each of IKKa, b, and c, were used for production of
high-titer recombinant baculovirus stocks (,1610
7 pfu/ml),
according to the manufacturer’s protocol. The pPuro plasmids
encoding human Bcl-2 or Bcl-XL were kindly provided by D.Y.
Shin (Dankook University, Korea) [68]. The plasmid pGEX-4T1-
SEK1 (K129R) [69] was used for production of GST-
SEK1(K129R) recombinant protein. Site-directed mutagenesis
was performed using a QuikChange mutagenesis kit (Stratagene).
Immuno-affinity purification of IKK complex and ESI-q-
TOF tandem mass spectrometry
HeLa S3 cells (20 ml packing volume from 20-l suspension
culture) were gently lysed in 200 ml of lysis buffer A (20 mM
HEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA, 2 mM EGTA,
1% Triton X-100, 10% glycerol, 1 mM AEBSF, 1 mM Na3VO4,
5 mM NaF, 10 ug/ml aprotinin and leupeptin). The lysate
(2 grams of total protein) was precleared with agarose beads alone
for 1 hr, and then incubated overnight with anti-IKKa-conjugated
agarose beads (2 mg/ml IgG, Santa Cruz Biotechnology). After
extensively washing four times with the lysis buffer, the beads were
loaded onto a column and rinsed twice with phosphate-buffered
saline. The precipitated proteins were eluted twice with 1 ml of
0.1 M glycine buffer (pH 2.5). The protein eluates were
immediately neutralized by adding 1 M Tris HCl buffer
(pH 8.0) and separated on a 10% denaturing gel. The gel was
subsequently stained with silver nitrate, and the silver-stained spots
were subjected to in-gel trypsin digestion with minor modifications
as follows. Briefly, the gel spots were excised with a scalpel and
destained by washing with 15 mM K4Fe(CN)6, 50 mM sodium
thiosulfate. The gel pieces were crushed, dehydrated by adding
acetonitrile, rehydrated by adding 10–20 ml of 25 mM ammonium
bicarbonate with 10 ng/ml of sequencing grade trypsin (Promega),
and incubated at 37uC for 15–17 h. The peptides in the
supernatant were transferred to a new tube and extracted twice
by adding 50 ml of a solution containing 60% acetonitrile and
0.1% trifluoroacetic acid. The extracted solutions were pooled and
evaporated to dryness in a SpeedVac vacuum centrifuge. The
tandem mass spectral (MS/MS) analysis for peptide sequencing
was done with nano flow reversed-phased HPLC/ESI/MS with a
mass spectrometer (Q-TOF Ultima
TM global, Waters Co. UK).
Peptides were separated by using a C18 reversed-phase 75mmi .
d.6150 mm analytical column (3 mm particle size, Atlantis
TM
dC18, Waters) with an integrated electrospray ionization Silica-
Tip
TM (610 mm, New Objective, USA). In detail, 5ml of peptide
mixtures were dissolved in buffer A (water/ACN/formic acid;
95:5:0.2, v/v), injected onto a column and eluted by a linear
gradient of 5–80% buffer B (water/ACN/formic acid; 5:95:0.2, v/
v) over 120 min. Samples were desalted on a line prior to
separation using a trap column (i.d. 0.35650 mm, OPTI-PAK
TM
C18, Waters) cartridge. Initially, the flow rate was set to 200 nL/
min by a split/splitless inlet and the capillary voltage (3.0 keV) was
applied to the HPLC mobile phase before spraying. Chromatog-
raphy was performed online using the instrument’s control
software MassLinx of Q-TOF Ultima
TM global. The mass
spectrometer was programmed to record scan cycles composed
of one MS scan followed by MS/MS scans of the eight most
abundant ions in each MS scan. MS parameters for efficient data-
dependent acquisition were intensity (.10) and number of
components (3,4) to be switched from an MS to MS/MS
analysis. Following positive identification, all identified peptides
from database search (Mascot) were excluded in the next run
analysis until full sequence coverage was obtained. Database
analyses using the database search programs including Mascot
(global search engine), Proteinlynx 2.1 (Waters Co., UK) and
MODi (Korea, http://modi.uos.ac.kr/modi/), provided almost
full sequence coverage on selective exclusion monitoring. MS/MS
spectra were matched against amino acid sequences in SwissProt.
Precusor ion mass corrections and a fragment ion mass tolerance
of 0.2 Da were used to consider as 2 missed cleavages.
Immunoelectron microscopy
The HeLa cells (1610
7 cells) were harvested and fixed for 1 hr,
at room temperature in 0.1 M cacodylate buffer (pH 7.2) that
contained 0.5% glutaraldehyde. After rinsing with cold distilled
water, they were dehydrated through an ethanol treatment series
at 4uC. They were infiltrated with LR White resin (London Resin,
Berkshire, England) at 4uC and embedded in LR White resin in a
gelatin capsules (Nisshin EM, Tokyo, Japan). Polymerization of the
resin was carried out at 50uC for 24 hrs. Serial sections (120–200
sections per one sample), 70 nm in thickness, were attached to
formvar-coated nickel grids. Sections were incubated in 50mM
glycine for 5 min at room temperature. After rinsing with PBS,
sections were incubated in 3% BSA for 30 mins at room
temperature. Then, they were incubated with primary antibodies
(goat anti-human Hsp60 (SC-1722), mouse anti-human IKKa
(SC-7606), mouse anti-IKKb (SC-8014), diluted 1:100 in PBS) for
2 hrs, at room temperature. After washing five times with Tween-
PBS (PBS plus 0.5% Tween-20), sections were treated with 20 nm-
and 40 nm-diameter colloidal gold conjugated to anti-goat and
anti-mouse IgG + IgM antibodies, respectively (BB International,
UK, diluted 1:20 in PBS) for 2 hrs, at room temperature. The
sections were washed three times with Tween-PBS and then
washed three times with distilled water. Sections were stained with
4% uranyl acetate for 5 mins and with lead citrate for 5 min. To
examine the specificity of the primary antibody, a treatment of
sections was performed with the same procedure without of the
primary antibody. For double staining, antibody reactions were
repeated with the second set of primary and secondary antibodies.
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transmission electron microscope (FEI Co., USA) and a JEM
ARM 1300S high-voltage electron microscope (JEOL, Japan).
Subcellular fractionation
The subcellular fractions for immunoprecipitation were ac-
quired by differential centrifugation. Briefly, the HeLa cells (2610
7
cells) were harvested, rinsed twice with ice-cold PBS, and
resuspended in 1 ml of a homogenization buffer (20 mM HEPES
(pH 7.5), 0.5 mM EDTA, 0.5 mM EGTA, 2 mM MgCl2,2 5m M
KCl, 1 mM AEBSF, 1 mM Na3VO4, 5 mM NaF, 5 mg/ml
aprotinin, and 5 mg/ml leupeptin) containing 0.25 M sucrose.
After rupturing the cells using a glass Dounce homogenizer, the
post-nuclear supernatants were obtained from the homogenate by
centrifugation at 750 g for 10 min. The supernatants were
separated into pellets (mitochondrial fraction) and supernatants
(cytosol fraction) by centrifugation at 15,000 g for 15 min. For
ODN transfected cells, the subcellular fractions were obtained
using the ProteoExtract subcellular proteome extraction kit
(Roche). The purity of each fraction was verified by selective
markers: a-tubulin as a cytosolic marker, inner membrane protein
cytochrome c oxidase 4 (COX4) and matrix protein peroxiredoxin
III (Prx III) [70] as mitochondrial markers. For best comparison,
the mitochondrial fraction was loaded at a volume of one-fifth of
the corresponding cytosolic fraction.
In vitro binding assay with recombinant proteins
The Sf9 insect cells were infected with each of recombinant
baculovirus stocks harboring IKKa-, IKKb-, and IKKc- encoding
bacmids. The insect lysates expressing (His)6-tagged IKKs were
incubated with 1.0 mg of GST-Hsp60 proteins pre-bound to
glutathione-Spharose beads (Amersham Pharmacia Biotech) at
4uC for 2 hrs. The beads were washed again three times with a
cold lysis buffer A. The proteins bound to the beads were eluted by
boiling in a SDS sample buffer and then subjected to immunoblot
analyses as indicated in Fig. 1c.
Transfection
The ODNs (200 nM, unless indicated) was transfected for
24 hrs using Oligofectamine
TM reagent (Invitrogen, USA). The
plasmid transfection was achieved using Fugene-6 reagent (Roche,
USA). The antibody was tranduced using a Chariot
TM protein
delivery kit (Active Motif Co., USA), according to the manufac-
turer’s instruction.
Immunoprecipitation and in vitro kinase assay
The HeLa cells were treated with or without TNF-a (10 ng/ml)
for the indicated time periods, rinsed once with cold PBS, and lysed
in the lysis buffer A. The cell lysates were precleared with 10 mlo f
protein A/G agarose beads (Amersham Biosciences) for 1 hr. The
clearedlysateswereincubated with 2 mg ofHsp60,IKKa,IKKb,or
IKKc antibodies for 3 hrs and mixed with 20 ml of protein A/G
agarose beads. The lysates were further rotated overnight at 4uC.
The beads were washed three times with 1 ml of lysis buffer A. The
final protein precipitates were subjected to immunoblot analyses.
The immune complexes were visualized by using an enhanced
chemiluminescence kit (Amersham Biosciences, USA).
For the in vitro kinase assay, the IKK, JNK1 or ASK-1 was
immunoprecipitated with anti-IKKc (FL-419) or anti-JNK1 (C-17)
or anti-ASK-1 (H-300) antibody, respectively. The beads contain-
ing the IKK complex or JNK1 were washed twice with lysis buffer
and further twice with a kinase buffer (20 mM HEPES, pH 7.4,
5 mM MgCl2,1 0 m Mb-glycerolphosphate, 1 mM Na3VO4,
2 mM NaF, and 1 mM dithiothreitol), and then incubated in
40 ml of a kinase buffer containing 10 mM ATP, 0.6 mCi [c-
32P]
ATP, and 2 mg of either GST-IkB (1–54) or GST-c-Jun or GST-
SEK1 (K129R) at 30uC for 30 min. The reaction was stopped by
adding 20 mlo f3 6SDS sample buffer. After boiling, the half of
reaction mixture was resolved on a 10% denaturing gel and the
radioactivity was detected by autoradiography. The other half of
reaction mixture was used for immunoblotting of the immuno-
precipitated kinase proteins (note: anti-ASK-1 antibody (F-9) for
detecting ASK-1).
Measurement of Intracellular ROS
Intracellular ROS generation was assessed with an oxidation
sensitive fluoresce dye, 5,6-chloromethyl-29,7 9-dichlorodihydro-
fluorescein diacetate (CM-H2DCFDA, Molecular Probes, USA) as
described [71]. The HeLa cells (3610
5) were plated on 35-mm
dishes and transfected with ODNs for 24 hrs. The cells were then
deprived of serum for 6 hrs and stimulated with TNF-a in phenol
red-free media for the indicated periods of time. After stimulation,
the cells were quickly rinsed with Krebs-Ringer solution and
incubated for 5 min with 5 mM CM-H2DCFDA. The DCF
fluorescence was collected for 10 seconds with an inverted
Axiovert200 fluorescence microscope (Zeiss). The relative DCF
fluorescence was obtained by averaging the fluorescence intensities
of the 60–80 cells in each image using ImageQuant
TM software
(GE Healthcare). Note that the detached round cells were omitted
from quantification.
RNase protection assay
ODN-pretreated HeLa cells were treated with or without TNF-
a (10 ng/ml) for the indicated times. The total RNA was extracted
with Trizol (Invitrogen). The ribonuclease (RNase) protection
assay was performed according to the manufacturer’s protocol (BD
PharMingen). Briefly, the human apoptosis template set hAPO-5
was labeled with [a-
32P]-uridine triphosphate. The RNA (10 mg)
and 6610
5 cpm of the labeled probes were subjected to
hybridization. After the RNase treatments, the protected probes
were resolved on 5% urea-polyacrylamide gel and detected by
autoradiography.
Quantitative PCR (qPCR)
Total RNA was extracted using Trizol reagent (Invitrogen) from
the HeLa cells stimulated with TNF-a for indicated periods of
time. RNA (1.5 mg) was reverse transcribed using ImProm-II RT
system (Promega). The real-time PCR was performed using
specific primers in the presence of SYBR Green (Applied
Biosystems) inside a fluorescent temperature cycler (ABI Prism
7000 sequence detection system, Applied Biosystems). The
fluorescence signals were quantified by a comparative cycle
threshold method. The actin mRNA was used for an endogenous
control.
Transgenic mice generation
The HA-tagged human Hsp60c lacking mitochondrial signal
sequence was PCR-amplified and subcloned into pCAGGS
transgenic (Tg) vector, which contains the chicken b-actin
promoter, using NheI and EcoRV sites. The HA-Hsp60c Tg
construct was linearized by digestion with SalI and PstI and then
microinjected into eggs from C57BL/6j females. The transgenic
founders were genotyped as described below. Two of the six
positive transgenic lines, designated T4 and T11, were chosen for
this study. The tail DNA was used for genotyping. In brief, mouse
tails were incubated overnight in 100 mM Tris, pH 8.0, 0.5 mM
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55uC. DNA was extracted with phenol:chloroform:isoamyl alcohol
(25:24:1) and precipitated with isopropanol. Genomic PCR was
performed by using two primer sets (set 1: forward primer, 59-
ATGGCTTCTAGCTATCCTTATG-39, and reverse primer, 59-
GTAGCAACCTGTGCAATTTCTTC-39; set 2: forward primer,
59-CTGCTAACCATGTTCATGCC-39 and reverse rimer, 59-
ACAAGTTTAGCTCCAATGTTTTTGTA-39). All the experi-
ments were performed with 4-week-old males.
Analysis of apoptotic cells in DEN-induced liver damage
The four-week-old male mice were injected intravenously with
phosphate-bufferedsaline(PBS,pH 7.4)orTNF-a(6 mg/kg)viathe
lateral tail vein 6 hrs before intraperitoneal administration of DEN
(10 mg/kg). After 48 hrs of DEN treatment, animals were sacrificed
and rapidly perfused with PBS followed by 4% paraformaldehyde.
The livers were removed and frozen in OCT embedding medium,
and then a series of tissue sections (10 mm in thickness) was obtained
in cryostat (Leica). The sections were incubated in 50 ml of terminal
deoxynucleotidyl transferase-mediate uridine 59-triphosphate-biotin
nick-end labeling (TUNEL) fluorescent reaction mixture (In situ
Cell Death Detection Kit, Roche Diagnostics) for 60 mins at 37uC
in a dark chamber, washed and subsequently counterstained with
49,69-diamidino-2-phenylindole (DAPI, 1 mg/ml, Sigma) for
30 mins. The sections were mounted using the Vectashield
mounting medium and examined using a LSM510 confocal laser-
scanning microscope (Carl Zeiss, Germany). TUNEL-positive cells
werecounted and averaged from threetissue sections per mouse.All
animal experiments were performed in compliance with the
institutional guidelines (Ewha Womans University, Korea) for the
care and use of laboratory animals.
In vitro osteoclastogenesis
The non-adherent bone marrow-derived monocytes/macrophag-
es (BMM) lineage cells derived from C57BL/6 mice were seeded and
cultured in a-MEM (Invitrogen) containing 10% FBS and M-CSF
(10 ng/ml, R&D systems). After 2 days, the nonadherent cells
including lymphocytes were removed and the adherent cells were
used as BMMs. The differentiation of BMM to osteoclast cells was
induced by treating them with either soluble RANKL (50 ng/ml,
Peprotech) or TNF-a (20 ng/ml) in the presence of M-CSF. After 5
days of induction, the cellswere fixed and stained for tartrate-resistant
acid phosphatase (TRAP). The cells were observed using a Zeiss
Axiovert 200 microscope (Carl Zeiss) equipped with a plan-Neofluor
objective lens. The images were analyzed using AxioVision 3.1
software (Carl Zeiss). The TRAP-positive multinucleated (.3n u c l e i )
cells were counted as osteoclast-like cells.
Statistics
Data were analyzed using Student’s t-test on SigmaPlot 8.0
software. The P values were derived to assess statistical significance
and indicated on figure panels.
Supporting Information
Figure S1 Action of Hsp60-specific antisense oligodeoxynucleo-
tide (AS-ODN). A. Schematic representation of two different
Hsp60 AS-ODNs. B. Hsp60 expression in mock- or ODN-
transfected HeLa cells. C. TNF-a-induced MAP kinase activation
in HeLa cells transfected with either mock or ODNs. The
activation was analyzed by using phospho-specific antibodies. The
phosphoblots were re-probed with whole protein antibodies for
equal loading. D. Activation of various transcription factors in
mock- or ODN-transfected HeLa cells. AP-1 and NF-AT
transcriptional activation were induced by epidermal growth
factor (EGF, 100 ng/ml). CRE transcriptional activation was
induced by forskolin (1 mM). E. TNF-a-induced NF-kB transcrip-
tional activation in 293T and A549 cells transfected with either
mock or ODNs as indicated. In D and E, the relative luciferase
activity was measured using an enhanced luciferase assay kit
(Promega) and normalized to the b-galactosidase activity. Data are
means 6 S.D. of four independent experiments (In E, *P,0.001
and **P,0.05 versus stimulated S-ODN-transfected cells).
Found at: doi:10.1371/journal.pone.0009422.s001 (2.28 MB EPS)
Figure S2 Selective role of cytosolic Hsp60 (Hsp60c) in IKK/NF-
kB signaling. A. TNF-a-induced JNK activation in HeLa cells
expressingHsp60c(HA tag).B - D. Activationofvarioustranscription
factors in HeLa cells transfected with either control vector or Hsp60c
(HA tag). AP-1 (B) and NF-AT (C) transcriptional activation were
induced by epidermal growth factor (EGF, 100 ng/ml). CRE
transcriptional activation (D) was induced by forskolin (1 mM). The
relative luciferase activity was measured using an enhanced luciferase
assay kit (Promega) and normalized to the b-galactosidase activity.
Data are means 6 S.D. of three independent experiments.
Found at: doi:10.1371/journal.pone.0009422.s002 (1.35 MB EPS)
Figure S3 DEN induces hepatic cell apoptosis. The four-week-
old C57BL/6j male mice were intraperitoneally injected with
DEN (10 mg/kg). After the indicated time periods of DEN
treatment, animals were sacrificed and processed to prepare tissue
sections and images as described in Experimental Procedures.
TUNEL positive cells were counted in three tissue sections per
mouse. Representative images (A) are shown. Data in the
quantitative graph (B) are mean 6 S.D. of TUNEL positive cells
per unit area.
Found at: doi:10.1371/journal.pone.0009422.s003 (4.30 MB EPS)
Figure S4 Mitochondrial release of Hsp60 in staurosporine-
treated HeLa cells. HeLa cells were treated with 1 mM
staurosporine and then subjected to subcellular fractionation using
the ProteoExtract subcellular proteome extraction kit (Roche).
Peroxiredoxin-III (Prx III) and a-tubulin were used as mitochon-
drial and cytosolic markers, respectively. In particular, an
antioxidant enzyme called Prx III (25-kDa in molecular size),
which is present in the mitochondrial matrix, was useful for
monitoring mitochondrial rupture. In western blots, the mito-
chondrial fractions were loaded at the volume of one-fifth of
cytosolic fraction for appropriate comparison.
Found at: doi:10.1371/journal.pone.0009422.s004 (1.31 MB EPS)
Figure S5 Cytosolic Hsp60 plays a significant survival role in
RANK-mediated osteoclastogenesis. The ODN-pretreated BMM
cells were treated with either RANKL (A) or TNF-a (B) for 5 days
in the presence of M-CSF. The TRAP-positive multinucleated
osteoclast cells were counted as described in the Experimental
Procedures. Data represent the means6SD of triplicate from one
of two independent sets of experiments, all of which showed
similar results (* P,0.02 versus the stimulated sense-ODN).
Representative pictures are shown.
Found at: doi:10.1371/journal.pone.0009422.s005 (7.72 MB EPS)
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